FORTIS - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 3.0
✅ Positive
The company demonstrated strong earnings growth with PAT increasing by 382% year-on-year, supported by a significant increase in DII holdings and a positive price target from Religare Broking. Fortis also maintains a relatively conservative debt-to-equity ratio, suggesting financial stability.
⚠️ Limitation
Despite the recent earnings surge, the stock's P/E ratio remains elevated at 366, indicating potential overvaluation compared to industry peers. The RSI is currently below 50, signaling potential bearish momentum and the MACD is negative, confirming a downtrend.
📉 Company Negative News
Religare Broking’s price target of Rs. 1040 suggests an optimistic outlook that may not be fully reflected in the current trading price. Northern TK Venture's substantial shareholding indicates potential strategic interest that could influence future market dynamics.
📈 Company Positive News
None found
🏭 Industry
The healthcare sector is generally considered defensive, exhibiting relative stability compared to cyclical industries. However, Fortis Healthcare operates within a competitive environment with increasing regulatory scrutiny and cost pressures, potentially impacting profitability.
🧾 Conclusion
Considering the current price of 944 ₹, an optimal entry zone would be between 910 ₹ and 930 ₹ based on identified support levels around the 200 DMA. An exit strategy should be set at 980 ₹ as a resistance level. Overall, the stock exhibits short-term bearish momentum due to weak RSI and MACD readings, but the recent earnings growth offers some upside potential for a cautious approach.